Patients on immunosuppressive therapy are not at increased risk for contracting COVID-19

Patients on immunosuppressive therapy are not at increased risk for contracting COVID-19

Patients on immunosuppressive therapy are not at increased risk for contracting COVID-19

Patients on immunosuppressive therapy for common skin and rheumatic diseases like psoriasis and rheumatoid arthritis are not at increased risk for contracting COVID-19 and should continue taking their medicine as prescribed, say Henry Ford Health System dermatology researchers in a study published in the Journal of the American Academy of Dermatology.